|
Molecular spectrum and carrier frequency of deletional hereditary persistence of fetal hemoglobin and delta-beta thalassemia in Malaysia
|
Faidatul Syazlin Abdul Hamid, Sabariah Md Noor, Mei I Lai, Samsol Kamal Mohd Bahari, Ezalia Esa, Ermi Neiza Mohd Sahid, Norafiza Mohd Yasin, Yuslina Mat Yusoff
|
p. 1-8
|
|
|
|
|
|
Novel agents and evolving strategies for anemia management in lower-risk myelodysplastic syndromes
|
Junshik Hong
|
p. 1-7
|
|
|
|
|
|
Treatment of transplant-ineligible multiple myeloma
|
Jongheon Jung
|
p. 1-7
|
|
|
|
|
|
Tandem autologous stem cell transplant in multiple myeloma patients with minimal residual disease : an explorative study
|
Sieun Oh, Sung-Soo Park, Jung Yeon Lee, Jae-Ho Yoon, Sung-Eun Lee, Hee-Je Kim, Seung-Hwan Shin, Young-Woo Jeon, Seung-Ah Yahng, Jin Jung, Ari Ahn, Myungshin Kim, Chang-Ki Min
|
p. 1-10
|
|
|
|
|
|
Aggressive natural killer cell leukemia therapy in the L-asparaginase era : why are we failing?
|
Sang Eun Yoon, Junhun Cho, Hyun-Young Kim, Seok Jin Kim, Won Seog Kim
|
p. 1-13
|
|
|
|
|
|
Unveiling the role of microRNAs, the PI3K/AKT pathway, and their associations in various types of leukemia : a comprehensive review
|
Amir Modarresi Chahardehi, Esfandiar Mali, Arya Afrooghe, Amirmasoud Asadi, Amirreza Khalaji, Hamed Soleimani Samarkhazan, Hananeh Esmaeil Beygi, Amirhossein Mohagheghi, Maryam Khanbabaei, Heliya Haghani, Reza Arefnezhad, Fatemeh Rezaei-Tazangi
|
p. 1-13
|
|
|
|
|
|
Early CD4 + T cell immune reconstitution as a biomarker for Epstein-Barr virus control following allogeneic transplantation
|
Kexin Lin, Wenwen Yang, Jiaxiu Yin, Jing Luo, Hao Zhou, Lanxiang Liu, Li Yang, Jie Luo, Lin Liu, Junli Mou
|
p. 1-10
|
|
|
|
|
|
Beyond anemia : unraveling neutrophil defects and infection susceptibility in β-Thalassemia
|
Chingiz Asadov, Gunay Aliyeva
|
p. 1-10
|
|
|
|
|
|
(Correspondence) Durable responses and favorable cost-effectiveness of rituximab‑based chemoimmunotherapy for primary cold agglutinin disease
|
Kenichi Ito, Tomoko Kitagawa, Saya Motohashi, Kazuhiko Hirano, Naohiro Sekiguchi
|
p. 1-6
|
|
|
|
|
|
(Correspondence) Current immunotherapeutic approaches for relapsed/refractory follicular lymphoma : bispecific antibodies and CAR T-Cell therapies
|
So Yeon Park, Gi-June Min
|
p. 1-6
|
|
|
|
|
|
(A) comparative study of hematologic response to ropeginterferon alfa-2b in hydroxyurea-resistant or intolerant polycythemia vera : a real-world data-based analysis
|
Sung-Eun Lee, Seug Yun Yoon, Sung-Yong Kim, Soo-Mee Bang, Insoo Lee, Jihyuk Lee, Junshik Hong
|
p. 1-7
|
|
|
|
|
|
Plasma interleukin‑12 levels as a potential biomarker of fatigue and quality of life in patients with primary immune thrombocytopenia
|
Sarthak Wadhera, Arihant Jain, Aarushi Sahni, Rudra Narayan Swain, Charanpreet Singh, Aditya Jandial, Ritu Aggarwal, Rekha Hans, Gaurav Prakash, Alka Khadwal, Sandeep Grover, Reena Das, Pankaj Malhotra
|
p. 1-8
|
|
|
|
|
|
Brentuximab vedotin combined with cisplatin, cytarabine, and dexamethasone treatment in transplant‑eligible Korean patients with relapsed or refractory Hodgkin’s lymphoma
|
Jun Ho Yi, Young Hoon Park, Myungwon Lee, Kwai Han Yoo, Junshik Hong, HyeonSeok Eom
|
p. 1-6
|
|
|
|
|
|
Insights into treatment‑free remission (TFR) outcomes in chronic myeloid leukaemia (CML) : a tertiary centre experience in Malaysia
|
Christopher Chin Keong Liam, Yang Liang Boo, Li Min Lim, Siew Lian Chong, Azizan Sharif, Yih Seong Wong, Veena Selvaratnam, Sen Mui Tan, Soo Min Lim
|
p. 1-7
|
|
|
|
|
|
Invasive fungal infections in hematologic diseases : evidence, challenges, and clinical practice
|
SungYeon Cho, Chae Eun Lee, Dukhee Nho, DongGun Lee
|
p. 1-7
|
|
|
|
|
|
(Correspondence) Measurable residual disease monitoring after hematopoietic stem cell transplantation
|
Saeam Shin
|
p. 1-3
|
|
|
|
|
|
(Correspondence) Translational investigation of tolinapant (ASTX660) in acute myeloid leukemia by integrating clinical, bioinformatic and pharmacological approaches
|
Keli Lima, Frederico Lisboa Nogueira, Catarina Sofia Mateus Reis‑Silva, Rita de Cássia Cavaglieri, Leticia Veras Costa‑Lotufo, João Agostinho Machado‑Neto, Eduardo Magalhães Rego
|
p. 1-5
|
|
|
|
|